@article{YKXB3867,
author = {Chengguo Zuo 和 Pengli Wang 和 Shufen Lin 和 Keling Wu 和 Mingkai Lin 和 Jian Ge},
title = {Clinical outcomes of Ex-PRESS glaucoma shunt in the management of refractory open angle glaucoma},
journal = {眼科学报},
volume = {31},
number = {3},
year = {2016},
keywords = {},
abstract = {Objective: To evaluate the efficacy and safety of the Ex-PRESS glaucoma shunt implantation in patients with refractory open angle glaucoma.
Methods: In total, 19 eyes with refractory glaucoma from 19 patients treated in our institution were retrospectively enrolled in this study. All patient underwent Ex-PRESS glaucoma shunt implantation with MMC (2 mg/6~8 mL, 2.5~4 min) and releasable sutures. The demographic features, preoperative and postoperative intraocular pressures (IOPs), best corrected visual acuity (BCVA), anterior chamber depth (ACD), cup-disc ratio (C/D), number of anti-glaucoma medications used, completed and qualified surgery success rates and postoperative complications were recorded to evaluate the outcomes of Ex-PRESS glaucoma shunt implantation.
Results: The complete success rate was 78.9%. Both the qualified success rate and the failure rate were 10.5%. Before surgery, the number of anti-glaucoma medications used was 3~5, and the mean IOP was 27.7±10.1 mmHg. After surgery, only three patients use 1~2 kinds of anti glaucoma medications. The reduction of IOP between groups was significant (P},
url = {https://ykxb.amegroups.com/article/view/3867}
}